| Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging C Schmidkonz, S Rauber, A Atzinger, R Agarwal, TI Götz, A Soare, ... Annals of the rheumatic diseases 79 (11), 1485-1491, 2020 | 126 | 2020 |
| 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer C Schmidkonz, M Cordes, D Schmidt, T Bäuerle, TI Goetz, M Beck, ... European journal of nuclear medicine and molecular imaging 45, 1862-1872, 2018 | 120 | 2018 |
| Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an 18F-labeled FAP inhibitor J Toms, J Kogler, S Maschauer, C Daniel, C Schmidkonz, T Kuwert, ... Journal of Nuclear Medicine 61 (12), 1806-1813, 2020 | 109 | 2020 |
| 99mTc‐MIP‐1404‐SPECT/CT for the detection of PSMA‐positive lesions in 225 patients with biochemical recurrence of prostate cancer C Schmidkonz, C Hollweg, M Beck, J Reinfelder, TI Goetz, JC Sanders, ... The Prostate 78 (1), 54-63, 2018 | 79 | 2018 |
| Interobserver variability of CT angiography for evaluation of aortic annulus dimensions prior to transcatheter aortic valve implantation (TAVI) C Schmidkonz, M Marwan, L Klinghammer, M Mitschke, A Schuhbaeck, ... European journal of radiology 83 (9), 1672-1678, 2014 | 63 | 2014 |
| A deep learning approach to radiation dose estimation TI Götz, C Schmidkonz, S Chen, S Al-Baddai, T Kuwert, EW Lang Physics in Medicine & Biology 65 (3), 035007, 2020 | 61 | 2020 |
| 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study C Bergmann, JHW Distler, C Treutlein, K Tascilar, AT Müller, A Atzinger, ... The Lancet Rheumatology 3 (3), e185-e194, 2021 | 57 | 2021 |
| SPECT/CT with the PSMA ligand 99mTc-MIP-1404 for whole-body primary staging of patients with prostate cancer C Schmidkonz, M Cordes, M Beck, TI Goetz, D Schmidt, O Prante, ... Clinical nuclear medicine 43 (4), 225-231, 2018 | 49 | 2018 |
| First experience with SPECT/CT using a 99mTc-labeled inhibitor for prostate-specific membrane antigen in patients with biochemical recurrence of prostate cancer J Reinfelder, T Kuwert, M Beck, JC Sanders, P Ritt, C Schmidkonz, ... Clinical Nuclear Medicine 42 (1), 26-33, 2017 | 49 | 2017 |
| Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy DN Dorst, M Rijpkema, M Buitinga, B Walgreen, MMA Helsen, E Brennan, ... Rheumatology 61 (7), 2999-3009, 2022 | 42 | 2022 |
| 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients C Schmidkonz, M Cordes, TI Goetz, O Prante, T Kuwert, P Ritt, M Uder, ... Annals of nuclear medicine 33, 766-775, 2019 | 42 | 2019 |
| A comparison of methods for adapting dose-voxel-kernels to tissue inhomogeneities T Götz, C Schmidkonz, EW Lang, A Maier, T Kuwert, P Ritt Physics in Medicine & Biology 64 (24), 245011, 2019 | 19 | 2019 |
| Assessment of myocardial fibrosis in patients with systemic sclerosis using [68Ga]Ga-FAPI-04-PET-CT C Treutlein, JHW Distler, K Tascilar, SC Fakhouri, AH Györfi, A Atzinger, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (6), 1629-1635, 2023 | 18 | 2023 |
| FAPI PET opens a new window to understanding immune-mediated inflammatory diseases T Kuwert, C Schmidkonz, O Prante, G Schett, A Ramming Journal of Nuclear Medicine 63 (8), 1136-1137, 2022 | 18 | 2022 |
| Dose voxel kernel prediction with neural networks for radiation dose estimation TI Götz, EW Lang, C Schmidkonz, T Kuwert, B Ludwig Zeitschrift für medizinische Physik 31 (1), 23-36, 2021 | 18 | 2021 |
| PSMA SPECT/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at … C Schmidkonz, TI Goetz, T Kuwert, P Ritt, O Prante, T Bäuerle, P Goebell, ... Annals of nuclear medicine 33, 891-898, 2019 | 18 | 2019 |
| Assessment of treatment response by 99mTc-MIP-1404 SPECT/CT: a pilot study in patients with metastatic prostate cancer C Schmidkonz, M Cordes, M Beck, TI Goetz, D Schmidt, O Prante, ... Clinical nuclear medicine 43 (8), e250-e258, 2018 | 18 | 2018 |
| 99mTc-MIP-1404 SPECT/CT for assessment of whole-body tumor burden and treatment response in patients with biochemical recurrence of prostate cancer C Schmidkonz, TI Götz, A Atzinger, P Ritt, O Prante, T Kuwert, T Bäuerle, ... Clinical nuclear medicine 45 (8), e349-e357, 2020 | 16 | 2020 |
| Quantification of translocation-specific ctDNA provides an integrating parameter for early assessment of treatment response and risk stratification in Ewing sarcoma M Krumbholz, J Eiblwieser, A Ranft, J Zierk, C Schmidkonz, AM Stütz, ... Clinical Cancer Research 27 (21), 5922-5930, 2021 | 15 | 2021 |
| Advanced thyroid carcinomas: neural network analysis of ultrasonographic characteristics M Cordes, TI Götz, EW Lang, S Coerper, T Kuwert, C Schmidkonz Thyroid Research 14 (1), 16, 2021 | 14 | 2021 |
Theresa Ida GötzVerified email at biologie.uni-r.de
